Practical implication
All electronic PV submissions must undergo new validation checks in accordance with the updated criteria to ensure compliance and accuracy.
The European Medicines Agency has revised the technical validation criteria for eCTD v4.0 submissions, introducing new validation checks and bug fixes. This change necessitates that electronic pharmacovigilance submissions, including Periodic Safety Update Reports (PSURs) and Risk Management Plans (RMPs), align with the updated validation criteria.
What changed: Revised technical validation rules for eCTD v4.0 submissions, requiring compliance for PSURs, RMPs, and other related filings.
Why it matters: These updates are critical for ensuring the accuracy and compliance of electronic submissions, impacting regulatory processes across the EU.
Practical implication: All electronic PV submissions must undergo new validation checks in accordance with the updated criteria to ensure compliance and accuracy.
View original source
Published from the Firecrawl policy change extraction pipeline.
